GSK, Moderna settle patent dispute over Moderna COVID, RSV shots:
British drugmaker GSK has settled lawsuits that accused Moderna's COVID-19 vaccines Spikevax ...
reut.rs/4sKNXII
News on this topic
GSK, Moderna settle patent dispute over Moderna COVID, RSV shots: British drugmaker GSK has settled lawsuits that accused Moderna's COVID-19 vaccines Spikevax ...
reuters.com/business/healthcare-pharmaceuticals/gsk-moderna-settle-patent-dispute-over-moderna-covid-rsv-shots-2026-11-06/
Similar to This
Previous
Health Canada approves Moderna's mRNA flu and flu-COVID combo vaccines: Health Canada has authorized Moderna’s mRNA vaccine for influenza, as well as its ...
ctvnews.ca/health/article/health-canada-approves-modernas-mrna-flu-and-flu-covid-combo-vaccines/
Moderna loses US government license defense in Northwestern patent case: A Delaware federal judge has rejected Moderna's argument that the US government's ...
reuters.com/legal/government/moderna-loses-us-government-license-defense-northwestern-patent-case-2026-10-01/
Pfizer, Moderna lose bids to escape Bayer US mRNA patent lawsuit: A federal judge in Delaware on Monday rejected Pfizer , BioNTech and Moderna's requests to ...
reuters.com/legal/legalindustry/pfizer-moderna-lose-bids-escape-bayer-us-mrna-patent-lawsuit-2026-09-28/
New COVID-19 vaccines approved for 2026-27 to combat latest active viruses: The FDA has approved four new COVID-19 vaccines for 2026-27 with some limits on who ...
sacbee.com/news/local/health-and-medicine/article317088563.html
Key FactsFDA approves four updated COVID-19 vaccines for 2026-27
Sep 1, 2026 · Reading time: ~30 sec.
Summary created with AI assistance · Source: sacbee.com
Summary created with AI assistance · Source: sacbee.com
- On August 27, the FDA authorized new formulations from Moderna, Pfizer-BioNTech, and Novavax-Sanofi; Moderna received two approvals.
- A May panel release said the vaccines are designed to better target variants currently circulating in the United States.
- Forbes reported they would be limited to people over 65 and younger at-risk individuals; approvals span ages six months to 64, depending on vaccine.
- Walgreens said the vaccines would be available shortly; CVS cited location-based timing, while no appointments were available there on September 1.
Moderna +10% after-hours as Moderna agrees to pay up to $2.25B to settle COVID vaccine patent dispute
finance.yahoo.com/news/moderna-agrees-pay-2-25-212613359.html
Moderna agrees to pay up to $2.87 billion to settle Covid-19 vaccine patent dispute
straitstimes.com/world/moderna-agrees-to-pay-up-to-2-87-billion-to-settle-covid-19-vaccine-patent-dispute
BioNTech sues Moderna for patent infringement regarding new coronavirus vaccine: The Mainz-based biotech company has sued its US competitor Moderna: A new ...
wiwo.de/unternehmen/industrie/biontech-verklagt-moderna-wegen-patentverletzung-bei-neuem-corona-impfstoff/100201806.html
With the holidays approaching, vaccinations are becoming increasingly important - | because respiratory illnesses continue to spread...
presseportal.de/pm/168924/6164991
Pfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent win: Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ...
reuters.com/legal/litigation/pfizer-biontech-lose-uk-appeal-overturn-modernas-covid-vaccine-patent-win-2025-08-01/
Paid articlePaywall How Moderna Went From Pandemic Hero to Vaccine Victim: The biotech’s mRNA vaccines were lauded by the first Trump administration but now are caught up in ...
wsj.com/health/pharma/trump-moderna-vaccine-struggle-a43b66fe
GSK sues Moderna for US patent infringement over COVID, RSV vaccines: British drugmaker GlaxoSmithKline sued Moderna in U.S. federal court in Delaware on Tuesday ...
reuters.com/business/healthcare-pharmaceuticals/glaxosmithkline-sues-moderna-us-patent-infringement-over-covid-vaccines-2024-10-15/
Paid articlePaywall Moderna Q2: Focus On The Light At The End Of The Tunnel: Moderna investors suffered a 20% hammering yesterday as the market reacted to downward guidance revision ...
seekingalpha.com/article/4709637-moderna-q2-earnings-worst-seems-over-maintain-buy
Biotech company Curevac is restructuring: GSK pays up to 1.4 billion for flu, Covid vaccines
faz.net/aktuell/wirtschaft/biotech-unternehmen-curevac-baut-um-gsk-zahlt-bis-zu-1-4-milliarden-fuer-grippe-covid-impfstoffe-19829418.html
Moderna shares are flying - Buy signal with announcement: A massive buy signal was generated.
deraktionaer.de/artikel/pharma-biotech/moderna-aktie-fliegt-kaufsignal-mit-ansage-20356702.html
Moderna says RSV vaccine 84% effective at preventing symptoms in older adults: Moderna Inc (MRNA.O) said on Tuesday that its experimental messenger RNA vaccine ...
reuters.com/business/healthcare-pharmaceuticals/moderna-says-rsv-vaccine-84-effective-preventing-symptoms-older-adults-2023-01-17/
A new kind of COVID vaccine could soon be available internationally: Data from Phase 3 trials, for two doses spaced three weeks apart, show the protein-based ...
popsci.com/science/new-gsk-sanofi-covid-vaccine/
Vaccine nationalism – and how it could affect us all: As studies warn that a delay in global COVID-19 immunization could affect all nations ...
weforum.org/agenda/2021/01/what-is-vaccine-nationalism-coronavirus-its-affects-covid-19-pandemic/
As U.S. coronavirus cases soar toward 200,000 a day, holiday travel is surging : A fall wave of the virus ushered in by colder weather is only worsening ...
washingtonpost.com/health/2020/11/21/coronavirus-thanksgiving-travel/
Next